Skip to main content
Fr Donate
  1. Home
  2. About us
  3. Media releases
  4. CCS elects four new members to its Board of Directors
Media Release

CCS elects four new members to its Board of Directors

  1. Home
  2. About us
  3. Media releases
  4. CCS elects four new members to its Board of Directors
The Canadian Cancer Society (CCS) is pleased to announce the appointment of four new directors to CCS’s Board of Directors.
2 min. read

TORONTO, ON - 

The Canadian Cancer Society (CCS) is pleased to announce the appointment of four new directors to CCS’s Board of Directors. The Board’s responsibilities include governance, leadership, public accountability, establishing CCS’s nationwide priorities and acting as a trustee on behalf of Canadians. 

“CCS is proud to welcome four Directors to help continue our sector leading work,” said Robert Lawrie, Chair of the CCS Board of Directors. “We are confident in the strong and varied expertise each brings to the cancer cause, and look forward to working together to unite and inspire all Canadians to take control of cancer.” 

As of July 15, 2020, CCS welcomed the following new Directors to its Board: 

Diane Gosselin has over 25 years of experience in financing innovative biomedical research. She is currently President and Chief Executive Officer of CQDM. During her tenure at CQDM, Diane has engaged a national network of over 2000 researchers across Canada and raised over $80M in funding from 14 of the largest pharmaceutical companies in the world. 

Yolande James is a lawyer-mediator and a political commentator for various CBC-Radio Canada programs. She also gives frequent public talks on various topics including immigration, diversity and gender equality in society and in politics. Yolande was elected to the Quebec National Assembly in 2004. She was the first Black female Member of the National Assembly, as well as Quebec’s first Black Cabinet Minister. 

Susan McPeak is co-founder of the McPeak-Sirois Group for Clinical Research in Breast Cancer, a unique private initiative bringing together public health institutions, one of the most effective breast cancer clinical research consortiums in Canada. Susan is a breast cancer survivor who participated in a life-saving clinical trial. Capitalizing on her 10+ years of experience in key management positions in marketing and business development, she committed to help make clinical research more accessible. 

Hilary M. Pearson, CM. LL.D has over 20 years of experience in foundation philanthropy in Canada. She currently serves on the Advisory Committee to the Masters in Philanthropy and Nonprofit Leadership program at Carleton University. From 2001 to 2019, she was the founding President of Philanthropic Foundations Canada. She also served on the Governor-General’s Advisory Committee on Volunteerism and Philanthropy and co-chaired the Advisory Committee on the Charitable Sector, advising the Federal Minister of Revenue on charitable policy and regulatory issues. 

To learn more about our new board members, and to see the full list of our national board, please visit cancer.ca. 

four new Board of Directors
CCS's new board members, from left to right: Diane Gosselin, Yolande James, Susan McPeak, Hilary M. Pearson
About the Canadian Cancer Society The Canadian Cancer Society is the only national charity that supports Canadians with all cancers in communities across the country. No other organization does what we do; we are the voice for Canadians who care about cancer. We fund groundbreaking research, provide a support system for all those affected by cancer and shape health policies to prevent cancer and support those living with the disease. 

Help us make a difference. Call 1-888-939-3333 or visit cancer.ca today. 

For more information, please contact: 
Rosie Hales 
Manager, Strategic Communications 
Canadian Cancer Society